« Return to News | CROs/Service Providers

Charles River and Metabolon partner on cancer research

Friday, April 6, 2012 10:54 AM

Charles River Discovery Services is partnering with Metabolon, a diagnostic products and services company based in Research Triangle Park, N.C., to enhance oncology research.

The collaboration will draw on Metabolon's in-depth analysis of metabolic data to identify both mechanism of action and biomarkers, which Charles River will combine with its preclinical oncology study expertise.

Working together, Metabolon and Charles River can provide:

  • MOA: elucidation, identification, characterization and validation of drug target candidates
  • Expertise in preclinical studies using validated in vivo and in vitro models
  • PK/PD, tumor growth delay, tumor growth inhibition, survival, combination and adjuvant study designs
  • Assessment of lead chemistries, lead ID, optimal dose, optimal combinations, sensitivity/resistance patterns and new indications for existing compounds
  • Development of biomarkers for preclinical PD, patient stratification/selection, translational models and efficacy

The new partnership will officially be announced at the upcoming American Association for Cancer Research (AACR) meeting.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.